Catalyst overview
Research summary
This catalyst tracks a Phase 3 data readout for TEV-’248 (ICS/SABA) in Asthma. The expected timing is based on the latest available company guidance and may change.
Collab. w/ Launch Therapeutics. Phase 3 results in H2 2026.
Verification
Confirm timing and program details against the company announcement or filing.